AstriVax enters clinical phase with its novel vaccine platform technology
June 24, 2024 01:00 ET
|
AstriVax
The first participants have been dosed in SAFYR, a Phase I clinical trial to test the safety and efficacy of two prophylactic vaccines developed with AstriVax technology. The study will also provide...
AstriVax Rounds Out Executive Team with Chief Business Officer (CBO) Dr. Gregory Fanning
March 19, 2024 02:00 ET
|
AstriVax
Dr. Fanning brings a wealth of experience in creating infectious disease pipelines by internal R&D and licensing As the CBO of AstriVax, he will lead the company’s business development, including...
AstriVax Awarded €3 Million Grant to Advance therapeutic Hepatitis B Vaccine
December 12, 2023 01:00 ET
|
AstriVax
The government grant is awarded by Flanders Innovation & Entrepreneurship (VLAIO).The grant will be used to accelerate the development of the company’s therapeutic vaccine targeting chronic...
AstriVax Strengthens Leadership Team by Welcoming Chief Development Officer (CDO) Dr. Mathieu Peeters and Chief Financial Officer (CFO) Barbara Freitag
October 10, 2023 01:00 ET
|
AstriVax
Dr. Mathieu Peeters brings an extensive clinical vaccine development track record from his senior roles at GSK Vaccines.Barbara Freitag joins AstriVax as an accomplished CFO in the biotech...
Dr. Christian Brander and Dr. Mala Maini Join World-class Scientific Advisory Board of AstriVax
August 22, 2023 01:00 ET
|
AstriVax
Christian Brander, Ph.D., is a leading expert on T cell responses to viral infections and brings an important blend of academic and biotech experience.Mala Maini, MD, Ph.D., is a professor of viral...
AstriVax Awarded €2.5 Million Grant to Advance Innovative Vaccine Platform
May 30, 2023 00:00 ET
|
AstriVax
The government grant is awarded by Flanders Innovation & Entrepreneurship (VLAIO).The grant will be used to accelerate the company’s vaccine platform. The non-dilutive financing builds upon the...
AstriVax, an innovative vaccine platform company, establishes scientific advisory board with world renowned leaders in vaccine development
March 24, 2023 02:00 ET
|
AstriVax
Emmanuel Hanon, PhD, will chair the company’s scientific advisory board. Professor Peter Piot (MD, PhD) and Professor Patrick Soentjens (MD, PhD) have been appointed as advisors. Together, they bring...
Dr. Jeanne Bolger to chair Board of Directors of Belgium-based vaccine technology company AstriVax
September 26, 2022 01:00 ET
|
AstriVax
Dr Jeanne Bolger brings over 35 years of management experience in the pharmaceutical industry to the new Belgium-based vaccine technology company.Last month, AstriVax closed its funding round – led by...
KU Leuven spin-off AstriVax raises € 30 million seed capital to build vaccine platform
August 25, 2022 01:00 ET
|
AstriVax
KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform Closing on € 30 million, AstriVax has raised the largest amount of seed capital in the history of spin-offs linked...